was read the article
array:24 [ "pii" => "S1578219017301579" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.03.038" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1650" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2017;108:501" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 453 "formatos" => array:3 [ "EPUB" => 36 "HTML" => 321 "PDF" => 96 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017301497" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.03.003" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1650" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2017;108:501" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 151 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 125 "PDF" => 25 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Consideraciones sobre los análisis de subgrupos en los ensayos clínicos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "501" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Considerations on Subgroup Analyses in Clinical Trials" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Coto-Segura" "autores" => array:1 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Coto-Segura" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219017301579" "doi" => "10.1016/j.adengl.2017.03.038" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301579?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017301497?idApp=UINPBA000044" "url" => "/00017310/0000010800000006/v3_201707250313/S0001731017301497/v3_201707250313/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S1578219017301658" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.04.002" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1664" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2017;108:502-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 601 "formatos" => array:3 [ "EPUB" => 34 "HTML" => 443 "PDF" => 124 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Opinion Article</span>" "titulo" => "Psoriasis and Psychiatric Disorders: The Next Frontier" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "502" "paginaFinal" => "505" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Psoriasis y comorbilidad psiquiátrica: la próxima frontera" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.M. Carrascosa, F. Ballesca" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J.M." "apellidos" => "Carrascosa" ] 1 => array:2 [ "nombre" => "F." "apellidos" => "Ballesca" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017301837" "doi" => "10.1016/j.ad.2017.04.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017301837?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301658?idApp=UINPBA000044" "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301658/v1_201706300050/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219017301580" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.01.003" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1617" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2017;108:500" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 427 "formatos" => array:3 [ "EPUB" => 39 "HTML" => 271 "PDF" => 117 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Antimicrobial Photodynamic Therapy: An Unexplored New Field" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "500" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Terapia fotodinámica antimicrobiana: un mundo por explorar" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Romaní" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Romaní" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S000173101730073X" "doi" => "10.1016/j.ad.2017.01.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101730073X?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301580?idApp=UINPBA000044" "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301580/v1_201706300050/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentary</span>" "titulo" => "Considerations on Subgroup Analyses in Clinical Trials" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "501" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "P. Coto-Segura" "autores" => array:1 [ 0 => array:3 [ "nombre" => "P." "apellidos" => "Coto-Segura" "email" => array:1 [ 0 => "pablocotosegura@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Unidad de Psoriasis, Hospital Universitario Central de Asturias Universidad de Oviedo, Oviedo, Asturias, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Consideraciones sobre los análisis de subgrupos en los ensayos clínicos" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">As clinicians, we routinely treat patients with drugs whose efficacy is supported by evidence from multicenter clinical trials, some of which include thousands of patients from different parts of the world. When it comes to treating a given patient, however, we need to know whether the beneficial effect described for the average patient will apply to this patient in particular. This can be done by subgroup analysis. Subgroup analysis is a valid tool, but it is not without risk and therefore any conclusions drawn need to be interpreted with caution.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Problems associated with subgroup analyses include loss of statistical power and multiple comparisons. I think that subgroup analyses are justified if they are designed to test a well-formulated hypothesis before the study starts. Inferences made on the basis of a posteriori analyses can be problematic both ethically and methodologically. In this issue, Valenzuela et al. report on the results of a subgroup analysis of the efficacy of ixekizumab in the treatment of psoriasis in the UNCOVER-3 trial in Latin American patients identified by ethnicity. Considering the limited number of patients studied and the difficulty of defining a homogeneous ethnic group for Latin America, their article deserves to be read with care and with consideration of the above-mentioned factors.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Coto-Segura P. Consideraciones sobre los análisis de subgrupos en los ensayos clínicos. Actas Dermosifiliogr. 2017;108:501.</p>" ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301579/v1_201706300050/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000006/v1_201706300050/S1578219017301579/v1_201706300050/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301579?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 12 | 6 | 18 |
2024 October | 67 | 34 | 101 |
2024 September | 75 | 22 | 97 |
2024 August | 100 | 56 | 156 |
2024 July | 95 | 40 | 135 |
2024 June | 82 | 28 | 110 |
2024 May | 79 | 27 | 106 |
2024 April | 73 | 27 | 100 |
2024 March | 70 | 24 | 94 |
2024 February | 65 | 28 | 93 |
2024 January | 49 | 36 | 85 |
2023 December | 37 | 11 | 48 |
2023 November | 58 | 26 | 84 |
2023 October | 48 | 18 | 66 |
2023 September | 62 | 34 | 96 |
2023 August | 37 | 12 | 49 |
2023 July | 36 | 35 | 71 |
2023 June | 37 | 20 | 57 |
2023 May | 43 | 26 | 69 |
2023 April | 29 | 22 | 51 |
2023 March | 42 | 26 | 68 |
2023 February | 46 | 26 | 72 |
2023 January | 31 | 41 | 72 |
2022 December | 37 | 39 | 76 |
2022 November | 16 | 19 | 35 |
2022 October | 25 | 18 | 43 |
2022 September | 19 | 42 | 61 |
2022 August | 24 | 31 | 55 |
2022 July | 19 | 41 | 60 |
2022 June | 19 | 23 | 42 |
2022 May | 38 | 38 | 76 |
2022 April | 29 | 44 | 73 |
2022 March | 42 | 56 | 98 |
2022 February | 31 | 33 | 64 |
2022 January | 25 | 39 | 64 |
2021 December | 30 | 43 | 73 |
2021 November | 47 | 55 | 102 |
2021 October | 38 | 62 | 100 |
2021 September | 30 | 45 | 75 |
2021 August | 32 | 35 | 67 |
2021 July | 25 | 39 | 64 |
2021 June | 21 | 31 | 52 |
2021 May | 32 | 42 | 74 |
2021 April | 65 | 73 | 138 |
2021 March | 57 | 37 | 94 |
2021 February | 45 | 35 | 80 |
2021 January | 31 | 28 | 59 |
2020 December | 42 | 32 | 74 |
2020 November | 32 | 39 | 71 |
2020 October | 18 | 11 | 29 |
2020 September | 40 | 23 | 63 |
2020 August | 40 | 23 | 63 |
2020 July | 19 | 26 | 45 |
2020 June | 33 | 32 | 65 |
2020 May | 10 | 12 | 22 |
2020 April | 13 | 12 | 25 |
2020 March | 24 | 11 | 35 |
2020 February | 2 | 1 | 3 |
2018 December | 3 | 0 | 3 |
2018 November | 1 | 0 | 1 |
2018 October | 3 | 0 | 3 |
2018 September | 2 | 0 | 2 |
2018 February | 20 | 5 | 25 |
2018 January | 17 | 8 | 25 |
2017 December | 38 | 9 | 47 |
2017 November | 20 | 3 | 23 |
2017 October | 24 | 9 | 33 |
2017 September | 36 | 9 | 45 |
2017 August | 50 | 13 | 63 |
2017 July | 84 | 23 | 107 |
2017 June | 23 | 17 | 40 |